2. Alanazi SA, Kamruzzaman MM, Islam-Sarker MN, Alruwaili M, Alhwaiti Y, Alshammari N, et al. Boosting Breast Cancer Detection Using Convolutional Neural Network. J Healthc Eng. 2021, 3:1–11. https://doi.org/10.1155/2021/5528622
3. Khin M, Shwe S, Oo KM, Win LL. Breast Cancer Awareness in Myanmar: Results of a Hospital-based Study in Mandalay. Arch Breast Cancer, 2021; 8(3):210-5. https://doi.org/10.32768/abc.202183210-215
4. Sadoh AE, Osime C, Nwaneri DU, Ogboghodo BC, Eregie CO, Oviawe O. Improving knowledge about breast cancer and breast self-examination in female Nigerian adolescents using peer education: a pre-post interventional study. BMC Womens Health. 2021; 21(1):328. https://doi.org/10.1186/s12905-021-01466-3
5. Shojaku H, Hori R, Yoshida T, Matsui K, Shimada K, Takayanagi N, Noguchi K. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: A case report. Medicine (Baltimore). 2021; 100(10):e24023. https://doi.org/10.1097/md.0000000000024023
6. Kobayashi-Taguchi K, Saitou T, Kamei Y, Murakami A, Nishiyama K, Aoki R, et al. Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging. Molecules. 2022; 27(10): 3340. https://doi.org/10.3390/molecules27103340
7. Mareti E, Vatopoulou A, Spyropoulou GA, Papanastasiou A, Pratilas GC, Liberis A, et al. Breast disorders in adolescence: a review of the literature. Basel. 2021;16(2):149-155. https://doi.org/10.1159/000511924
8. Zhang J, Guo X, Wang B, Cui W. Automatic detection of invasive ductal carcinoma based on the fusion of multi-scale residual convolutional neural network and SVM. IEEE Access. 2021; 4(9):40308-17.https://doi.org/10.1109/access.2021.3063803
9. Siddiqui F, Gupta S, Dubey S, Murtuza S, and Jain A., Classification and Diagnosis of Invasive Ductal Carcinoma Using Deep Learning. IEEE Xplore 2020; 10:242-47. https://doi.org/10.1109/Confluence47617.2020.9058077
10. Saadallah F, Bouraoui I, Naija L, Sakhri S, Zemni I, Hassouna JB, et al. Coexistence of invasive ductal breast carcinoma and fibroadenoma. Pan Afr Med J. 2019; 33:139. https://doi.org/10.11604/pamj.2019.33.139.17140
11. Athavale V, Khetan V. Knudson to embryo selection: A story of the genetics of retinoblastoma. Taiwan J. Ophthalmol. 2018; 8(4):196-204.
12. Manickavinayaham S, Velez-Cruz R, Biswas AK, Chen J, Guo R, Johnson DG. The E2F1 transcription factor and RB tumour suppressor moonlight as DNA repair factors. Cell Cycle. 2020; 19(18):2260-2269. https://doi.org/10.1080/15384101.2020.1801190
13. Rubin SM, Sage J, Skotheim JM. Integrating old and new paradigms of G1/S control. Mol Cell. 2020; 80(2):183-92. https://doi.org/10.1016/j.molcel.2020.08.020
14. Nagasaka M, Potugari B, Nguyen A, Sukari A, Azmi AS, Ou SH. KRAS Inhibitors–yes but what next? Direct targeting of KRAS–vaccines, adoptive T cell therapy and beyond. Cancer Treat Rev. 2021; 101:102309. https://doi.org/10.1016/j.ctrv.2021.102309
15. Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020;17(3):153-168.
16. Teruyama F, Kuno A, Murata Y, Nakagawa T, Shiba‐Ishii A, Yuguchi S, et al. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15‐year period: A case report. Pathology International. 2022; 72(9):457-463. https://doi.org/10.1111/pin.13257
17. Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet. 2020; 52(3):331-341
18. Yu K, Tan L, Lin L, Cheng X, Yi Z, Sato T. Deep-learning-empowered breast cancer auxiliary diagnosis for 5GB remote E-health. IEEE Wireless Communications. 2021; 28(3):54-61. https://doi.org/10.1109/mwc.001.2000374
19. Bellynda M, Yarso KY. Patient satisfaction in the complete removal of giant breast fibroadenoma under vacuum-associated breast biopsy procedure. Open Access Maced J Med Sci. 2021; 9©:40-2.
20. Kanavati F, Tsuneki M. Breast invasive ductal carcinoma classification on whole slide images with weakly-supervised and transfer learning. Cancers. 2021;13(21):5368. https://doi.org/10.3390/cancers13215368
21. Odeyemi AT, Ayantola KJ, Peter S. Molecular characterization of bacterial isolates and physicochemical assessment of well water samples from hostels at Osekita, Iworoko-Ekiti, Ekiti State. Am J Microbiol Res. 2018;6(1):22-32.
22. Maddalena M, Mallel G, Nataraj NB, Shreberk-Shaked M, Hassin O, Mukherjee S, et al. TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment Proc Natl Acad Sci USA. 2021; 118(23): e2025631118. https://doi.org/10.1073/pnas.2025631118
23. Hassani M, Al-Janabi AA. Comparative analysis of synonymous codon usage bias in Dengue viruses. BMC Genomics. 2021;22(1):468.
24. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000; 14(19):2393-409.
25. Guzman C, Bagga M, Kaur A, Westermarck J, Abankwa D. Colony formation assay. Bio-protocol. 2020;10(4):e3510
26. Thomas DM, Balan V. Oncogenes and cell proliferation. Curr Opin Cell Biol. 2012; 24(2):163-9.
27. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 2017;11(12):1470-82
28. Riller Q, Rieux-Laucat F. RASopathies: From germline mutations to somatic and multigenic diseases. Biomed J. 2021; 44(4):422-432. https://doi.org/10.1016/j.bj.2021.06.004
29. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res. 2007;5(2):195-201.
30. Überall I, Kolář Z, Trojanec R, Berkovcova J, Hajduch M. The status and role of ErbB receptors in human cancer. Exp Mol Pathol. 2008; 84(2):79-89.
31. Winters RM, Williams CP, Wallace K, Mehta A, Soisson AP. Cervical cancer: a global health crisis. Cancer Cytopathol. 2017;125(7):561-9.
32. Wong ML, Ngai C, Lai V, Cheung AN, Cheung TH. The role of HPV DNA testing in cervical cancer screening: A large-scale retrospective study in a tertiary referral center in Hong Kong. Gynecol Oncol. 2018;151(3):470-6.
33. Wolf SP, Wen FT, Schreiber H. Criteria to make animal studies more relevant to treating human cancer. Curr Opin Immunol. 2022; 74:25-31. https://doi.org/10.1016/j.coi.2021.09.002
34. Escher TE, Satchell KJF. RAS degraders: The new frontier for RAS-driven cancers. Mol Ther. 2023;31(7):1904-1919. doi: 10.1016/j.ymthe.2023.03.017
- Abstract viewed - 464 times
- Retinoblastoma (Rb) and Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Mutation Signature in Fibroadenoma and Invasive Adenocarcinoma of the Breast downloaded - 217 times
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
© VO Ekundina, AO Kehinde, OV Azuh, S Okah, 2023
Affiliations
VO Ekundina
Affiliation not stated
AO Kehinde
Affiliation not stated
OV Azuh
Affiliation not stated
S Okah
Affiliation not stated
How to Cite
Retinoblastoma (Rb) and Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Mutation Signature in Fibroadenoma and Invasive Adenocarcinoma of the Breast
- VO Ekundina ,
- AO Kehinde ,
- OV Azuh ,
- S Okah
Vol 9 No 1 (2023): Volume 9 Number 1
Submitted: Jan 11, 2024
Published: Jan 11, 2024
Abstract
Background: Most pathological lesions of the breast present as a tumour or tumours. The majority of these lesions are due to genetic mutations from environmental and lifestyle factors. Kirsten rat sarcoma viral oncogene homolog (KRAS) gene and Retinoblastoma (Rb) gene play vital roles in the control of the cell cycle and cell proliferation.
Materials and Methods: A total of 20 formalin fixed paraffin embedded blocks, consisting of benign fibroadenoma (FA) (10) and malignant invasive ductal adenocarcinoma (IDC) (10) breast specimen were retrieved from the Pathological Archives for this case-control, retrospective study. Small portions of tissue were cut from the tissue blocks and ground in a sterile mortar and pestle with 500µl of extraction buffer for deoxyribonucleic acid (DNA) extraction and polymerase chain reaction (PCR) amplification, purification and sequencing. Ethical approval was obtained from the Ethics committee of the Federal Teaching Hospital.
Results: In Rb gene single nucleotide polymorphism (SNP) mutation frequency, there was 100% transition mutation in Fibroadenoma (FA) and 79% transition, 16% transversion and 5% indel mutation in IDC. In Rb gene functional mutation frequency, there was 100% missense mutation in FA, and 72% missense, 28% silent and 0% nonsense mutation in IDC. In KRAS gene SNP mutation frequency, there was 71% transition, 21% transversion, and 8% indel mutation in IDC. KRAS gene functional mutation, there was 86% missense, 14% silent and 0% nonsense mutation in IDC.
Conclusion: The majority of mutations arise as a missense class. This demonstrates that missense mutations possibly play a significant role in breast cancer aetiology. There is a paucity of data on the mutation of Rb and KRAS genes on FAs and IDC in this part of the world hence the need for the present study.
Keywords: Mutation, Retinoblastoma, KRAS, Fibroadenoma, Invasive Adenocarcinoma, Breast Cancer